An important limitation of the available evidence is the relatively short duration of follow-up in many included trials
15 A similar study on venous ulcers in CVI showed a reduction of the ulcer area by 38.6% with Pycnogenol and by 31.5% in the control group using diosmin/hesperidin (Figure 3)
Cannot redeclare control with same name "grid_1_qv_style_tab_hover"
Lower cagrilintide doses in combinations When combining, can reduce cagrilintide: 1.8mg cagrilintide + 2.4mg semaglutide: Still very effective (14-18% weight loss estimated) Better tolerated than both at 2.4mg Cost savings on cagrilintide Consider if GI-sensitive 1.2mg cagrilintide + 2.4mg semaglutide: Modest benefit from cagrilintide addition Minimal GI side effects from cagrilintide Semaglutide does heavy lifting May still achieve 12-15% total weight loss Testing approach: Start with standard doses (both 2.4mg) If intolerable, reduce cagrilintide first Maintain semaglutide at 2.4mg (well-tolerated, established) Find optimal cagrilintide dose for your tolerance Maintenance dosing after weight loss Strategies to sustain results long-term
If approved, a prescription is issued and sent to a partner pharmacy
Out-of-pocket costs are the strongest predictor of abandonment: High OOP costs drive non-adherence, especially in obesity, where coverage is limited and stigma persists
